Fatigue Reduction in Chronic Kidney Disease (CKD)
- Conditions
- Chronic Kidney DiseasesFatigue
- Registration Number
- NCT06768983
- Lead Sponsor
- NYU Langone Health
- Brief Summary
In this pilot trial, investigators will pilot test a cognitive behavioral intervention for acceptability and proof of concept for a larger future trial to be submitted for federal funding. This is a one-group design with qualitative and quantitative data collection integrated into the intervention.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 20
- Interest in participating in a fatigue study
- Age ≥18 years old
- Estimated glomerular filtration rate (eGFR) 15-44 mL/min/1.73 m2
- Ability and willingness to provide informed consent
- Ability to speak English
- Ability to walk
- Ability to join remote study sessions via WebEx
- Current involvement in an activity/exercise program
- High likelihood of a kidney transplant within 6 months (assessed via the medical record)
- Any safety concerns about increased walking (assessed via the medical record)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Session Adherence Up to Week 12 Measure of feasibility; calculated as the percentage of planned sessions that were actually attended by participants.
- Secondary Outcome Measures
Name Time Method Change in Functional Assessment of Chronic Illness Therapy (FACIT) - Fatigue Score Baseline, Week 12 The FACIT Measurement System is a collection of health-related quality of life (HRQOL) questionnaires targeted to the management of chronic illness. The Fatigue Subscale comprises 13 items and measures symptoms of fatigue. Each item is rated on a scale from 0 (not at all) to 4 (very much); the total score is the sum of responses and ranges from from 0 to 52; lower scores indicate greater fatigue.
Change in Dialysis Symptom Index (DSI) Score Baseline, Week 12 The DSI is 30-item assessment of CKD-related unpleasant symptoms. Each item is rated on a scale from 0 (not at all) to 4 (very much). The total score is the sum of the responses, ranging from 0 to 120. A higher score indicates a greater symptom burden.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
NYU Langone Health
🇺🇸New York, New York, United States